Compounds > platinum

Page last updated: 2024-08-22

platinum and mesna

platinum has been researched along with mesna in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (75.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
DeWoskin, RS; Riviere, JE	1
Almadrones, L; Hakes, T; Hoskins, W; Jones, W; Lewis, JL; Markman, M; Pizzuto, F; Reichman, B; Rubin, S	1
Cabanillas, FC; Hagemeister, FB; McLaughlin, P; Rodriguez, MA; Romaguera, JE; Swan, F; Velasquez, W	1
Berkhof, J; Boven, E; Hausheer, FH; Ruijter, R; van der Born, K; van der Vijgh, WJ; Verschraagen, M	1

Trials

3 trial(s) available for platinum and mesna

Article	Year
Ifosfamide and mesna in previously treated advanced epithelial ovarian cancer: activity in platinum-resistant disease. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1992, Volume: 10, Issue:2 Topics: Acute Kidney Injury; Adult; Aged; Carcinoma; Drug Evaluation; Drug Resistance; Female; Humans; Ifosfamide; Mesna; Middle Aged; Ovarian Neoplasms; Platinum	1992
A phase II trial of mesna/ifosfamide, mitoxantrone and etoposide for refractory lymphomas. Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Mesna; Middle Aged; Mitoxantrone; Platinum; Prospective Studies; Recurrence; Remission Induction; Salvage Therapy; Survival Rate; Treatment Failure	1995
Pharmacokinetics and preliminary clinical data of the novel chemoprotectant BNP7787 and cisplatin and their metabolites. Clinical pharmacology and therapeutics, 2003, Volume: 74, Issue:2 Topics: Adult; Aged; Antineoplastic Agents; Area Under Curve; Chromatography, High Pressure Liquid; Cisplatin; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Mesna; Middle Aged; Platinum; Prospective Studies; Tissue Distribution	2003

Other Studies

1 other study(ies) available for platinum and mesna

Article	Year
Cisplatin-induced loss of kidney copper and nephrotoxicity is ameliorated by single dose diethyldithiocarbamate, but not mesna. Toxicology and applied pharmacology, 1992, Volume: 112, Issue:2 Topics: Animals; Blood Urea Nitrogen; Body Weight; Cisplatin; Copper; Creatinine; Ditiocarb; Female; Kidney; Kidney Diseases; Mesna; Platinum; Rats; Rats, Inbred F344; Zinc	1992